3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
112
Lymphoma
66
Lymphoma, Large B-Cell, Diffuse
50
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
29
Lymphoma, Follicular
22
Burkitt Lymphoma
22
Multiple Myeloma
19
Leukemia
16
Hodgkin Disease
16
Neoplasms
14
Neoplasm Metastasis
13
Lymphoma, B-Cell
13
Lymphoma, Mantle-Cell
11
Lymphoma, Large-Cell, Anaplastic
11
Lymphoma, T-Cell
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, T-Cell, Peripheral
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Recurrence
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, AIDS-Related
4
Immunoblastic Lymphadenopathy
4
Prostate Cancer Metastatic
3
Primary Myelofibrosis
3
Polycythemia Vera
3
Plasmablastic Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
Prednisone
×
Clear all
No trials found.